Lv2
164 积分 2022-11-29 加入
抗肿瘤药物申报联合用药早期临床试验的考虑
18天前
已完结
药物制剂安全性研究评价的常见问题讨论
23天前
已完结
药物制剂安全性评价及常见问题
23天前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
7个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
7个月前
已完结
Claudin 18.2 as a novel therapeutic target
7个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
8个月前
已完结
皖公网安备34019202002308
